global and national testing covid. clinical trials from kidney to cancer partnered with big pharm and japan tobacco for kidney. market cap 2.2 billion on revenue of 900 million. market cap to revenue 2.2, industry average minimum 5. shorts at 30%. insider buying.
Comments